The Valley Desk

ArticleJAMA internal medicinePublished

Effectiveness of Empagliflozin vs Dapagliflozin for Kidney Outcomes in Type 2 Diabetes

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
JAMA internal medicine
Published
Subject terms
Humans; Diabetic Nephropathies; Diabetes Mellitus, Type 2; Disease Progression; Benzhydryl Compounds; Glucosides; Hypoglycemic Agents; Glomerular Filtration Rate; Treatment Outcome; Aged; Middle Aged; Denmark
PubMed ID
39836391
PubMed Central ID
PMC11877187
Added to directory
Source checked

Report a correction or request removal